Irradiation (300 rad) of guinea pigs and subsequent transfer of bone marrow cells was followed by a decreased frequency of rabbit erythrocyte rosettes (a T lymphocyte marker) in peripheral lymphoid organs. Neonatal thymectomy did not potentiate this effect. A reduced amount of rosette-forming cells was also found in the thymus of irradiated animals. This was not affected by treatment with thymosin in vivo or in vitro, and was probably due to a reduced viability of the cells after irradiation since it was demonstrated that rosette formation among dead thymus cells was significantly less than among living cells. Incubation of normal thymocytes in non-supplemented medium for 2–4 h at 37 °C was also followed by a diminished rosette-forming capacity. The addition of thymosin or bovine serum albumin prevented both the decrease of rosette-forming cells and the reduction of viable cells during incubation. Thus, a diminished rosette formation may have been caused by reduced viability after incubation as well as after irradiation. The rosette-forming ability of only some dead thymocytes may reflect different subpopulations.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.